Non-Hodgkin Lymphoma Diagnostics Market Size, Share and Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2024 – 2032
Report ID: GMI4283
Download Free PDF
Authors:
Monali Tayade,
Non-Hodgkin Lymphoma Diagnostics Market Size
Non-Hodgkin Lymphoma Diagnostics Market size will expand at a significant pace between 2024 and 2032 due to the high demand for growing public awareness and advanced treatment options. It is one of the most common cancers and accounts for about 4% of all cancer cases in the US. The American Cancer Society estimates that about 80,470 people will be diagnosed with NHL in 2022. Several FDA-approved therapeutic medications and enhanced diagnostic methods are developed to improve treatment outcomes. However, rising medical costs and strict regulatory requirements could restrain industry expansion to some extent.
Non-Hodgkin Lymphoma Diagnostics Market Trends
The notable trends in the industry reflect advancements in diagnostic technologies and an evolving landscape of healthcare. There is increasing integration of molecular diagnostics and genetic profiling in lymphoma diagnosis, providing more precise and personalized insights for effective treatment strategies.
Additionally, there is a growing emphasis on early detection, leading to the development of innovative diagnostic tools and techniques that enable swift and accurate identification of NHL. These trends collectively signify a progressive shift towards more sophisticated and patient-centric approaches, fostering advancements in diagnostic capabilities and contributing to improved patient outcomes.
Non-Hodgkin Lymphoma Diagnostics Market Analysis
The biopsy testing segment is anticipated to account for a sizable share of the non-hodgkin lymphoma (NHL) diagnostics market by 2032. Biopsy testing is commonly used in excisional or incisional biopsy procedures. They are frequently employed for diagnosing illnesses such as infections and inflammatory disorders. The introduction of advanced testing methods, such as liquid biopsies, is likely to facilitate industry gains over the coming years.
Hospitals are likely to see a high demand for non-hodgkin lymphoma diagnostics by 2032. These healthcare setting have easy accessibility to quick and precise diagnostic tests as well as skilled specialists. This not only reduces the use of unnecessary medications but also shortens hospital stays and improves patient outcomes. The increasing desire of patients to receive cancer diagnoses in hospitals.
Asia Pacific non-hodgkin lymphoma diagnostics market will register a sizable revenue share by 2023 driven by rising healthcare spending and a growing patient base. Increased propensity for urban lifestyles and rapid economic development are responsible for the rise in cancer cases across the region. Advancements in the healthcare sector will influence by the availability of high diagnostic facilities and developments in testing methods.
North America industry is also predicted to grow at a commendable rate due to rising cases of cancer and high spending on its diagnostic solutions. According to the American Cancer Society, around $246 billion is expected to be spent in the U.S. on cancer-related healthcare by 2030. The technological developments and investments in the healthcare domain and the presence of robust regulatory frameworks.
Non-Hodgkin Lymphoma Diagnostics Market Share
The leading companies operating in the non-hodgkin lymphoma diagnostics industry include:
The collaborative efforts between diagnostic companies and research institutions are driving the exploration of novel biomarkers, enhancing the diagnostic accuracy and prognostic value.
Non-Hodgkin Lymphoma Diagnostics Industry News
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Security & defense sector journals and trade press
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 30+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →